Absci and Merck collaborate to develop new enzymes
Drug and target discovery company Absci has signed a research collaboration with Merck to produce new enzymes and will use Drug Creation
Stay updated with breaking news from Deep Learning Enabled Drug Creation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drug and target discovery company Absci has signed a research collaboration with Merck to produce new enzymes and will use Drug Creation
Absci Announces Research Collaboration with Merck Collaboration to leverage Absci's Deep Learning-Enabled Drug Creation™ and Bionic Protein™... | January 7, 2022